𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reduced antiplatelet therapy after drug-eluting stenting: Multicenter janus flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months—matrix study

✍ Scribed by Salvatore Cassese; Giuseppe De Luca; Bruno Villari; Sergio Berti; Pietro Bellone; Alfonso Alfieri; Antonio Montinaro; Gaetano Quaranta; Paolo Marraccini; Federico Piscione; on behalf of MATRIX Study Investigators

Book ID
112018402
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
168 KB
Volume
80
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Double-Blind, Multicenter
A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial
✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 653 KB
Rationale and design of the dual antipla
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions
✍ Laura Mauri; Dean J. Kereiakes; Sharon-Lise T. Normand; Stephen D. Wiviott; Davi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB